ABCL 4.65 ▼ -2.52% Live Trading Data - Stocknear

AbCellera Biologics Inc.

NASDAQ: ABCL · Real-Time Price · USD
4.65
-0.12 (-2.52%)
At close: Sep 25, 2025, 3:59 PM
4.64
-0.22%
After-hours: Sep 25, 2025, 05:24 PM EDT
-2.52%
Bid 4.6
Market Cap 1.39B
Revenue (ttm) 32.88M
Net Income (ttm) -165.66M
EPS (ttm) -0.56
PE Ratio (ttm) -8.3
Forward PE -10.65
Analyst Buy
Dividends n/a
Ask 4.83
Volume 3,401,784
Avg. Volume (20D) 5,626,436
Open 4.60
Previous Close 4.77
Day's Range 4.50 - 4.72
52-Week Range 1.89 - 5.82
Beta 0.65
Ex-Dividend Date n/a

About ABCL

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ABCL
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for ABCL stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
AbCellera Biologics Inc. is scheduled to release its earnings on Nov 3, 2025, after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+0.24%
ABCL stock has given up its prior gain. AbCellera ... Unlock content with Pro Subscription
1 month ago
+0.24%
AbCellera Biologics shares are trading higher after the company reported better-than-expected Q2 financial results and announced the dosing initiation of its Phase 1 ABCL635 trial.